Literature DB >> 33012871

The Use of Prazosin in Treatment of Drug Dreams in Adolescents with Substance Use Disorder: Two Case Reports.

Arpit Aggarwal1, Victoria Lindegaard1.   

Abstract

~ Nightmares are psychologically distressing events that may cause significant effects on mental health, physical well-being and overall quality of life, in addition to their negative impact on quality and duration of sleep. Drug dreams are a variant of nightmares and a known phenomenon in addiction medicine, and have been studied as a potential causative factor in relapse of substance use. Recent studies have noted that addictive behaviors and drug dreams share a similar neurobiological pathway, and that certain neurotransmitters, most notably those of the noradrenergic system, may underlie these complex processes. This has led to the theory that alleviation of drug dreams and suppression of involved neurocircuits may potentially reduce subsequent craving and relapse in the treatment of substance use disorders, with an important potential agent being the alpha-1 antagonist, prazosin.
Copyright © 1964–2019 by MedWorks Media Inc, Los Angeles, CA All rights reserved. Printed in the United States.

Entities:  

Keywords:  adolescents; drug dreams; prazosin

Mesh:

Substances:

Year:  2020        PMID: 33012871      PMCID: PMC7511147     

Source DB:  PubMed          Journal:  Psychopharmacol Bull        ISSN: 0048-5764


  6 in total

1.  Two Case Reports on Use of Prazosin for Drug Dreams.

Authors:  Ganesh Gopalakrishna; Oluwole Popoola; Austin Campbell; Marina A Nemetalla
Journal:  J Addict Med       Date:  2016 Mar-Apr       Impact factor: 3.702

2.  Addicts' drug-related dreams: their frequency and relationship to six-month outcomes.

Authors:  G Christo; C Franey
Journal:  Subst Use Misuse       Date:  1996-01       Impact factor: 2.164

3.  Relationship between drug dreams, affect, and craving during treatment for substance dependence.

Authors:  Hélène Tanguay; Antonio Zadra; Daniel Good; Francesco Leri
Journal:  J Addict Med       Date:  2015 Mar-Apr       Impact factor: 3.702

Review 4.  Treatment of nightmares with prazosin: a systematic review.

Authors:  Simon Kung; Zelde Espinel; Maria I Lapid
Journal:  Mayo Clin Proc       Date:  2012-08-09       Impact factor: 7.616

Review 5.  Targeting the Noradrenergic System in Posttraumatic Stress Disorder: A Systematic Review and Meta-Analysis of Prazosin Trials.

Authors:  Domenico De Berardis; Stefano Marini; Nicola Serroni; Felice Iasevoli; Carmine Tomasetti; Andrea de Bartolomeis; Monica Mazza; Daniela Tempesta; Alessandro Valchera; Michele Fornaro; Maurizio Pompili; Gianna Sepede; Federica Vellante; Laura Orsolini; Giovanni Martinotti; Massimo Di Giannantonio
Journal:  Curr Drug Targets       Date:  2015       Impact factor: 3.465

6.  Drug dreams in outpatients with bipolar disorder and cocaine dependence.

Authors:  Tonia Yee; Dana C Perantie; Nafisa Dhanani; E Sherwood Brown
Journal:  J Nerv Ment Dis       Date:  2004-03       Impact factor: 2.254

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.